Restylane Benefit Over Collagen Will Show In Data, Not Labeling Terms – CEO
This article was originally published in The Gray Sheet
Executive Summary
Pivotal trial data inclusion in Medicis/Q-Med's Restylane labeling will be sufficient to demonstrate superiority over Inamed's Zyplast, should it earn FDA approval, according to Medicis